The Purple Sky Store
Crop Hoodie (Embroidered Purple Ribbon)
Crop Hoodie (Embroidered Purple Ribbon)
Couldn't load pickup availability
Beyond its fashionable appeal, this hoodie supports an important cause. 40% of all revenue from the Courage Cropped Hoodie goes to Sky Foundation, a non-profit that funds pancreatic cancer research, allowing each purchase to make a meaningful impact.
- Soft, lightweight fabric (6.5 oz/yd² or 220.39 g/m²) for comfortable wear
- 52% airlume combed and ring-spun cotton, 48% poly fleece blend
- Cropped body with raw hem for a modern look
- Dropped shoulder cut for a relaxed fit
- Dyed-to-match drawstrings for a coordinated finish
Note: Wear your courage proudly with a hoodie that combines style and support for pancreatic cancer research.
Share












Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...